DXRX Diaceutics PLC

2.502USD190.00 GBp · LSE+1.33%Mkt Cap: 212.60M USDP/E: —

Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for pr…

Institutional holders1 on file

Key Statistics

Company
Market Cap212.60M USD
Enterprise Value201.31M USD
Revenue (TTM)54.42M USD
Gross Profit41.45M USD
Net Income (TTM)127.73K USD
Revenue/Share0.64 USD
Last Price2.502 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees205
CountryGB
SectorHealthcare
IndustryHealth Information Services
ISINGB00BJQTGV64
Valuation
P/E (Trailing)—
P/E (Forward)46.04
PEG—
EV/EBITDA39.63
EV/Revenue3.70
P/S3.91
P/B4.16
EPS (TTM)0.00 USD
EPS (Forward)0.05 USD
52W Range
0.000090% of range2.765
52W High2.765 USD
52W Low0.0000 USD
Profitability
Gross Margin81.90%
Oper. Margin-1.92%
EBITDA Margin9.34%
Profit Margin0.25%
ROE0.24%
ROA0.19%
ROIC0.06%
ROCE0.10%
Growth
Revenue Growth19.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF1.55M USD
CapEx (TTM)8.49M USD
FCF Margin-1.09%
FCF Yield-0.28%
Net Debt-7.91M USD
Net Debt/EBITDA-1.56
Net Debt/FCF—
Balance Sheet
Debt/Equity0.03
Current Ratio2.56
Quick Ratio2.33
Book Value/Sh0.60 USD
Cash/Share0.13 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.2 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)3.160 USD
Upside (mean)+26.3%
Target Range2.831 USD – 3.555 USD
2.831+26.3% to mean3.555
# Analysts5
Ownership
Shares Out.84.97M
Float47.82M
Insiders22.67%
Institutions74.30%
Technical
SMA 502.505 (-0.1%)
SMA 2002.118 (+18.1%)
Beta0.77
S&P 52W Chg12.08%
Avg Vol (30d)525.16K
Avg Vol (10d)1.76M
Technical Indicators
RSI (14)45.2
MACD-0.5919
MACD Signal1.0743
MACD Hist.-1.6661
BB Upper2.771 USD
BB Middle2.599 USD
BB Lower2.427 USD
BB Width13.25%
ATR (14)0.1067 USD
Vol Ratio (20d)0.11x

About Diaceutics (LON: DXRX)

›

Diaceutics (LON: DXRX) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Health Information Services industry, part of the Healthcare sector, and reports about 205 employees.

The shares were at 190.00 GBp on 19 November 2026, up 15.9% over 52 weeks.

Its market capitalisation is 161.45M GBP.

Diaceutics reports return on equity of 0.2%, an operating margin of -1.9% and revenue up 19.9% year over year.

It holds more cash than debt, a net cash position of 6.01M GBP. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 5 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 240.00 GBp is 26.3% above the current price.